Yankai Wen, Cynthia Ju – 14 March 2020

Birgit Schwacha‐Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour – 14 March 2020

Michael R. Lucey, Ashwani K. Singal – 14 March 2020

Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng – 14 March 2020 – The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), the pathogen of 2019 novel coronavirus disease (COVID‐19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS‐CoV‐2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS‐CoV‐2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases.

Birgit Schwacha‐Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour – 14 March 2020

Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson – 14 March 2020 – Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning worldwide epidemic whose etiology reflects multiple interactions between environmental and genetic factors. Here, we review the major pathways and dominant genetic modifiers known to be relevant players in human NAFLD and which may determine key components of the heritability of distinctive disease traits including steatosis and fibrosis.

Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson – 14 March 2020 – Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning worldwide epidemic whose etiology reflects multiple interactions between environmental and genetic factors. Here, we review the major pathways and dominant genetic modifiers known to be relevant players in human NAFLD and which may determine key components of the heritability of distinctive disease traits including steatosis and fibrosis.

Monika Sarkar, Deirdre Sawinski, Lisa Coscia, the American Society of Transplantation, Women’s Health Community of Practice – 14 March 2020

Josh Levitsky, Elisa Gordon – 14 March 2020

Michael R. Lucey, Ashwani K. Singal – 14 March 2020